BML-259
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Product Specifications
CAS Number
267654-00-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
260.36
Molecular Formula
C14H16N2OS
Notes
Research use only, not for human use.
Receptor
Antifungal|Antiviral
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1487731-01 0.02 mg (E-Coli)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details 
MBS1487731-02 0.02 mg (Yeast)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details MBS1487731-03 0.1 mg (E-Coli)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details 
MBS1487731-04 0.1 mg (Yeast)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details 
MBS1487731-05 0.02 mg (Baculovirus)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details MBS1487731-06 0.02 mg (Mammalian-Cell)
Recombinant Synechococcus sp. ATP synthase gamma chain (atpG)
Ask
View Details